Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators

We analyzed our 10‐year cumulative experience of 40 consecutive patients with idiopathic dilated Cardiomyopathy and associated ventricular tachyarrhythmias, treated with implantable Cardioverter defibrillators. Dilated Cardiomyopathy was defined as left ventricular ejection fraction (EF) ≤50% with n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 1991-11, Vol.14 (11), p.1905-1910
Hauptverfasser: FAZIO, GREGORY, VELTRI, ENRICO P., TOMASELLI, GORDON, LEWIS, RICHARD, GRIFFITH, LAWRENCE S.C., GUARNIERI, THOMAS
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1910
container_issue 11
container_start_page 1905
container_title Pacing and clinical electrophysiology
container_volume 14
creator FAZIO, GREGORY
VELTRI, ENRICO P.
TOMASELLI, GORDON
LEWIS, RICHARD
GRIFFITH, LAWRENCE S.C.
GUARNIERI, THOMAS
description We analyzed our 10‐year cumulative experience of 40 consecutive patients with idiopathic dilated Cardiomyopathy and associated ventricular tachyarrhythmias, treated with implantable Cardioverter defibrillators. Dilated Cardiomyopathy was defined as left ventricular ejection fraction (EF) ≤50% with no defineable etiology. Patient characteristics included: 24 male, mean age 52 years, mean EF = 33%, New York Heart Association Class I–III, presenting syndrome—cardiac arrest (n = 28), syncope/near syncope (n = 12). At 2.5 years mean follow‐up, there were 16 deaths: one operative, three sudden, two incessant ventricular tachycardia/ventricular fibrillation (VT/VF), six heart failure, and four noncardiac. The actuarial mortality at 1 and 4 years was 0% and 14% for sudden death, 11% and 34% for cardiac death. The projected mortality was 52% and 78% for same time intervals (P < 0.01). No useful baseline variable predicted who would or would not receive an ICD shock in follow‐up. ICD therapy appears effective in reducing sudden death mortality in this high risk population.
doi_str_mv 10.1111/j.1540-8159.1991.tb02788.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72577542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72577542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4095-d2d0a81923597ea45d63cabd1be57e38b0f47e77e5d47307ee8cb82216e45ad53</originalsourceid><addsrcrecordid>eNqVkUFv0zAUxy0EGmXwEZAsDtyS2UkcO5yY2q0bVKOHbkhcLCd5JS5JnNkubT4M35VkqcYZX3x47_977-mH0AdKQjq8i11IWUICQVkW0iyjoc9JxIUIjy_Q7Ln0Es0ITXggYpG9Rm-c2xFCUpKwM3RGeURpxmfoz8q0P4MN2AZfm7o2h-C-w2aL18praL3DB-0rfGda7YoKGl3gha6VhxLPlS21aXrTKV_1WLUlfhgSVhf7Wlm8UUXVK2ur3leNVg5vLDzlnoC3TVer1qu8hhPoN1gPFi9gq3Or62GGse4terVVtYN3p_8c3V9fbeY3werb8nZ-uQqKhGQsKKOSKEGzKGYZB5WwMo0LlZc0B8YhFjnZJhw4B1YmPCYcQBS5iCKaQsJUyeJz9HHidtY87sF52Qz3wrBFC2bvJI8Y5yyJhsZPU2NhjXMWtrKzulG2l5TI0Y3cyVGAHAXI0Y08uZHHIfz-NGWfN1D-i04yhvrnqX7QNfT_QZbry_kVzch4SDAhtPNwfEYo-0umPOZMfr9byoevP5aLdP1Fivgv_tqy7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72577542</pqid></control><display><type>article</type><title>Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>FAZIO, GREGORY ; VELTRI, ENRICO P. ; TOMASELLI, GORDON ; LEWIS, RICHARD ; GRIFFITH, LAWRENCE S.C. ; GUARNIERI, THOMAS</creator><creatorcontrib>FAZIO, GREGORY ; VELTRI, ENRICO P. ; TOMASELLI, GORDON ; LEWIS, RICHARD ; GRIFFITH, LAWRENCE S.C. ; GUARNIERI, THOMAS</creatorcontrib><description>We analyzed our 10‐year cumulative experience of 40 consecutive patients with idiopathic dilated Cardiomyopathy and associated ventricular tachyarrhythmias, treated with implantable Cardioverter defibrillators. Dilated Cardiomyopathy was defined as left ventricular ejection fraction (EF) ≤50% with no defineable etiology. Patient characteristics included: 24 male, mean age 52 years, mean EF = 33%, New York Heart Association Class I–III, presenting syndrome—cardiac arrest (n = 28), syncope/near syncope (n = 12). At 2.5 years mean follow‐up, there were 16 deaths: one operative, three sudden, two incessant ventricular tachycardia/ventricular fibrillation (VT/VF), six heart failure, and four noncardiac. The actuarial mortality at 1 and 4 years was 0% and 14% for sudden death, 11% and 34% for cardiac death. The projected mortality was 52% and 78% for same time intervals (P &lt; 0.01). No useful baseline variable predicted who would or would not receive an ICD shock in follow‐up. ICD therapy appears effective in reducing sudden death mortality in this high risk population.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/j.1540-8159.1991.tb02788.x</identifier><identifier>PMID: 1721197</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Cardiomyopathy, Dilated - mortality ; Cardiomyopathy, Dilated - therapy ; Death, Sudden - epidemiology ; Death, Sudden, Cardiac - epidemiology ; dilated Cardiomyopathy ; Electric Countershock - instrumentation ; Female ; Follow-Up Studies ; Humans ; implantable Cardioverter defibrillator ; Life Tables ; Male ; Middle Aged ; Prognosis ; Prostheses and Implants ; Regression Analysis ; Risk Factors ; Tachycardia - mortality ; Tachycardia - therapy ; Time Factors</subject><ispartof>Pacing and clinical electrophysiology, 1991-11, Vol.14 (11), p.1905-1910</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4095-d2d0a81923597ea45d63cabd1be57e38b0f47e77e5d47307ee8cb82216e45ad53</citedby><cites>FETCH-LOGICAL-c4095-d2d0a81923597ea45d63cabd1be57e38b0f47e77e5d47307ee8cb82216e45ad53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1540-8159.1991.tb02788.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1540-8159.1991.tb02788.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1721197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FAZIO, GREGORY</creatorcontrib><creatorcontrib>VELTRI, ENRICO P.</creatorcontrib><creatorcontrib>TOMASELLI, GORDON</creatorcontrib><creatorcontrib>LEWIS, RICHARD</creatorcontrib><creatorcontrib>GRIFFITH, LAWRENCE S.C.</creatorcontrib><creatorcontrib>GUARNIERI, THOMAS</creatorcontrib><title>Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>We analyzed our 10‐year cumulative experience of 40 consecutive patients with idiopathic dilated Cardiomyopathy and associated ventricular tachyarrhythmias, treated with implantable Cardioverter defibrillators. Dilated Cardiomyopathy was defined as left ventricular ejection fraction (EF) ≤50% with no defineable etiology. Patient characteristics included: 24 male, mean age 52 years, mean EF = 33%, New York Heart Association Class I–III, presenting syndrome—cardiac arrest (n = 28), syncope/near syncope (n = 12). At 2.5 years mean follow‐up, there were 16 deaths: one operative, three sudden, two incessant ventricular tachycardia/ventricular fibrillation (VT/VF), six heart failure, and four noncardiac. The actuarial mortality at 1 and 4 years was 0% and 14% for sudden death, 11% and 34% for cardiac death. The projected mortality was 52% and 78% for same time intervals (P &lt; 0.01). No useful baseline variable predicted who would or would not receive an ICD shock in follow‐up. ICD therapy appears effective in reducing sudden death mortality in this high risk population.</description><subject>Cardiomyopathy, Dilated - mortality</subject><subject>Cardiomyopathy, Dilated - therapy</subject><subject>Death, Sudden - epidemiology</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>dilated Cardiomyopathy</subject><subject>Electric Countershock - instrumentation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>implantable Cardioverter defibrillator</subject><subject>Life Tables</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Prostheses and Implants</subject><subject>Regression Analysis</subject><subject>Risk Factors</subject><subject>Tachycardia - mortality</subject><subject>Tachycardia - therapy</subject><subject>Time Factors</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkUFv0zAUxy0EGmXwEZAsDtyS2UkcO5yY2q0bVKOHbkhcLCd5JS5JnNkubT4M35VkqcYZX3x47_977-mH0AdKQjq8i11IWUICQVkW0iyjoc9JxIUIjy_Q7Ln0Es0ITXggYpG9Rm-c2xFCUpKwM3RGeURpxmfoz8q0P4MN2AZfm7o2h-C-w2aL18praL3DB-0rfGda7YoKGl3gha6VhxLPlS21aXrTKV_1WLUlfhgSVhf7Wlm8UUXVK2ur3leNVg5vLDzlnoC3TVer1qu8hhPoN1gPFi9gq3Or62GGse4terVVtYN3p_8c3V9fbeY3werb8nZ-uQqKhGQsKKOSKEGzKGYZB5WwMo0LlZc0B8YhFjnZJhw4B1YmPCYcQBS5iCKaQsJUyeJz9HHidtY87sF52Qz3wrBFC2bvJI8Y5yyJhsZPU2NhjXMWtrKzulG2l5TI0Y3cyVGAHAXI0Y08uZHHIfz-NGWfN1D-i04yhvrnqX7QNfT_QZbry_kVzch4SDAhtPNwfEYo-0umPOZMfr9byoevP5aLdP1Fivgv_tqy7g</recordid><startdate>199111</startdate><enddate>199111</enddate><creator>FAZIO, GREGORY</creator><creator>VELTRI, ENRICO P.</creator><creator>TOMASELLI, GORDON</creator><creator>LEWIS, RICHARD</creator><creator>GRIFFITH, LAWRENCE S.C.</creator><creator>GUARNIERI, THOMAS</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199111</creationdate><title>Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators</title><author>FAZIO, GREGORY ; VELTRI, ENRICO P. ; TOMASELLI, GORDON ; LEWIS, RICHARD ; GRIFFITH, LAWRENCE S.C. ; GUARNIERI, THOMAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4095-d2d0a81923597ea45d63cabd1be57e38b0f47e77e5d47307ee8cb82216e45ad53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Cardiomyopathy, Dilated - mortality</topic><topic>Cardiomyopathy, Dilated - therapy</topic><topic>Death, Sudden - epidemiology</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>dilated Cardiomyopathy</topic><topic>Electric Countershock - instrumentation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>implantable Cardioverter defibrillator</topic><topic>Life Tables</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Prostheses and Implants</topic><topic>Regression Analysis</topic><topic>Risk Factors</topic><topic>Tachycardia - mortality</topic><topic>Tachycardia - therapy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FAZIO, GREGORY</creatorcontrib><creatorcontrib>VELTRI, ENRICO P.</creatorcontrib><creatorcontrib>TOMASELLI, GORDON</creatorcontrib><creatorcontrib>LEWIS, RICHARD</creatorcontrib><creatorcontrib>GRIFFITH, LAWRENCE S.C.</creatorcontrib><creatorcontrib>GUARNIERI, THOMAS</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FAZIO, GREGORY</au><au>VELTRI, ENRICO P.</au><au>TOMASELLI, GORDON</au><au>LEWIS, RICHARD</au><au>GRIFFITH, LAWRENCE S.C.</au><au>GUARNIERI, THOMAS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>1991-11</date><risdate>1991</risdate><volume>14</volume><issue>11</issue><spage>1905</spage><epage>1910</epage><pages>1905-1910</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>We analyzed our 10‐year cumulative experience of 40 consecutive patients with idiopathic dilated Cardiomyopathy and associated ventricular tachyarrhythmias, treated with implantable Cardioverter defibrillators. Dilated Cardiomyopathy was defined as left ventricular ejection fraction (EF) ≤50% with no defineable etiology. Patient characteristics included: 24 male, mean age 52 years, mean EF = 33%, New York Heart Association Class I–III, presenting syndrome—cardiac arrest (n = 28), syncope/near syncope (n = 12). At 2.5 years mean follow‐up, there were 16 deaths: one operative, three sudden, two incessant ventricular tachycardia/ventricular fibrillation (VT/VF), six heart failure, and four noncardiac. The actuarial mortality at 1 and 4 years was 0% and 14% for sudden death, 11% and 34% for cardiac death. The projected mortality was 52% and 78% for same time intervals (P &lt; 0.01). No useful baseline variable predicted who would or would not receive an ICD shock in follow‐up. ICD therapy appears effective in reducing sudden death mortality in this high risk population.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1721197</pmid><doi>10.1111/j.1540-8159.1991.tb02788.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0147-8389
ispartof Pacing and clinical electrophysiology, 1991-11, Vol.14 (11), p.1905-1910
issn 0147-8389
1540-8159
language eng
recordid cdi_proquest_miscellaneous_72577542
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Cardiomyopathy, Dilated - mortality
Cardiomyopathy, Dilated - therapy
Death, Sudden - epidemiology
Death, Sudden, Cardiac - epidemiology
dilated Cardiomyopathy
Electric Countershock - instrumentation
Female
Follow-Up Studies
Humans
implantable Cardioverter defibrillator
Life Tables
Male
Middle Aged
Prognosis
Prostheses and Implants
Regression Analysis
Risk Factors
Tachycardia - mortality
Tachycardia - therapy
Time Factors
title Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A45%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Follow-Up%20of%20Patients%20with%20Nonischemic%20Dilated%20Cardiomyopathy%20and%20Ventricular%20Tachyarrhythmias%20Treated%20with%20Implantable%20Cardioverter%20Defibrillators&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=FAZIO,%20GREGORY&rft.date=1991-11&rft.volume=14&rft.issue=11&rft.spage=1905&rft.epage=1910&rft.pages=1905-1910&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/j.1540-8159.1991.tb02788.x&rft_dat=%3Cproquest_cross%3E72577542%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72577542&rft_id=info:pmid/1721197&rfr_iscdi=true